PPH Legal Blog

Prescriptions for the drug class Glitazones were up a third in the UK from 2005 to 2006 in patients with diabetes.
The drug group glitazones is a group of drugs that has “glitazone” as part of its name. It includes the popular oral blood sugar medication Avandia in its class.
In the time period studied, Avandia (or rosiglitazone) […]

[Read more →]

November is Pulmonary Hypertension Awareness month. This year marks the ten-year anniversary of a national initiative to create awareness for what once was an obscure and terminal illness. Today millions of dollars are committed to the search for a cure!
Ten years ago, very little knowledge about PPH was available. It is so rare and without […]

[Read more →]

A study released by DiabetesDynamics USA shows that half of patients that were on Avandia were switched to a different drug type or insulin. The other half of patients taking Avandia were switched to drugs such as Actos, Actoplus Met and Duetact which also happen to be glitazones. This is the same classification of drug […]

[Read more →]

Arena Pharmaceuticals, a small San Diego based company with nothing currently on the market, has announced that they may have a drug almost identical to fen-phen on the market by 2010.
The drug, which is nearing the end of its first year of trials and is as of yet unnamed, is identical to fen-phen in that […]

[Read more →]

An FDA official has called for higher standards for approval following the recent problems with Avandia and other drugs used to treat diabetes.
The problems and scandal involving Avandia stem from a May report by the New England Journal of Medicine that said that diabetes patients taking Avandia had a 43% higher risk of heart attack […]

[Read more →]